journal article·2018-08-15

Vortex Fluidic Mediated Synthesis of Macroporous Bovine Serum Albumin-Based Microspheres

Xuan Luo, Ahmed Hussein Mohammed Al-Antaki, David P. Harvey, Yinlan Ruan, Shan He, Wei Zhang, Colin L. Raston

ACS Applied Materials & Interfaces· Volume 10· Issue 32
Publisher page

Abstract

Macroporous bovine serum albumin (BSA) nanoparticles with controllable diameter were readily fabricated in a rapidly rotating angled glass tube in a vortex fluidic device (VFD). Systematically varying the rotational speed and the ratio of BSA, ethanol, and glutaraldehyde led to conditions for generating ca. 600 nm diameter macroporous particles that have intrinsic fluorescence emission at 520 nm when excited at 490 nm. The presence of the macropores increased the absorption efficiency of rhodamine B with potential applications for drug delivery purpose, compared with BSA nanoparticles having surfaces devoid of pores. Further control over the size of BSA nanoparticles occurred in the presence of C-phycocyanin protein during the VFD processing, along with control of their shape, from spheres to pockets, as established in exploring the parameter space of the microfluidic device.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Microfluidic and Bio-sensing Technologies · Microfluidic and Capillary Electrophoresis Applications · Innovative Microfluidic and Catalytic Techniques Innovation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

ARC Centre of Excellence for Nanoscale BioPhotonics, Institute of Photonics and Advanced Sensing, Adelaide University, Adelaide, South Australia 5005, Australia

Department of Food Science and Engineering, School of Chemistry Chemical Engineering, Guangzhou University, Guangzhou 510006, China

Funding

Australian Research Council · Government of South Australia

References (44)

Show source-provided references
1. 10.1021/bc500621h10.1021/bc500621h ↗
2. 10.1016/j.ijpharm.2010.10.04110.1016/j.ijpharm.2010.10.041 ↗
3. 10.2147/nsa.s11701810.2147/nsa.s117018 ↗
4. 10.1016/j.jconrel.2011.07.03110.1016/j.jconrel.2011.07.031 ↗
5. 10.1016/s0378-5173(99)00370-110.1016/s0378-5173(99)00370-1 ↗
6. 10.1016/s0378-5173(99)00420-210.1016/s0378-5173(99)00420-2 ↗
7. 10.1023/a:100757003036810.1023/a:1007570030368 ↗
8. 10.1021/bp025631710.1021/bp0256317 ↗
9. 10.1016/j.ijpharm.2010.10.01210.1016/j.ijpharm.2010.10.012 ↗
10. Aimi, M.; Nemori, R.; Miyashita, Y.; Yokoyama, H. Enzymatically Crosslinked Protein Nanoparticles. U.S. Patent 0,004,278 A1, 2009.
11. 10.1016/s0378-5173(03)00134-010.1016/s0378-5173(03)00134-0 ↗
12. 10.1021/acsami.6b0085710.1021/acsami.6b00857 ↗
13. 10.1155/2012/68610810.1155/2012/686108 ↗
14. 10.4103/2230-973x.8243210.4103/2230-973x.82432 ↗
15. 10.1186/1556-276x-9-34310.1186/1556-276x-9-343 ↗
16. 10.1016/j.ijpharm.2007.03.03610.1016/j.ijpharm.2007.03.036 ↗
17. 10.2217/nnm.12.4910.2217/nnm.12.49 ↗
18. 10.2478/s11532-007-0017-910.2478/s11532-007-0017-9 ↗
19. 10.7567/jjap.55.06gp1210.7567/jjap.55.06gp12 ↗
20. 10.1007/s00396-002-0661-810.1007/s00396-002-0661-8 ↗
21. 10.1007/s00396-003-1041-810.1007/s00396-003-1041-8 ↗
22. 10.1002/app.1165310.1002/app.11653 ↗
23. 10.1016/j.aca.2006.04.05010.1016/j.aca.2006.04.050 ↗
24. 10.1016/j.actbio.2008.11.01610.1016/j.actbio.2008.11.016 ↗
25. 10.1016/j.aquatox.2017.11.01710.1016/j.aquatox.2017.11.017 ↗
26. 10.1038/srep2286510.1038/srep22865 ↗
27. 10.1039/c7re00197e10.1039/c7re00197e ↗
28. 10.1021/acssuschemeng.6b0075610.1021/acssuschemeng.6b00756 ↗
29. 10.1039/c3ra42831a10.1039/c3ra42831a ↗
30. 10.1002/anie.20160401410.1002/anie.201604014 ↗
31. 10.1002/cptc.20170020610.1002/cptc.201700206 ↗
32. 10.1039/c2cc17611d10.1039/c2cc17611d ↗
33. 10.1002/cbic.20140242710.1002/cbic.201402427 ↗
34. 10.1016/j.chroma.2006.05.07310.1016/j.chroma.2006.05.073 ↗
35. 10.1021/la301457v10.1021/la301457v ↗
36. 10.1146/annurev.biochem.67.1.50910.1146/annurev.biochem.67.1.509 ↗
37. 10.1371/journal.pone.012875610.1371/journal.pone.0128756 ↗
38. 10.1016/s0014-5793(04)00134-610.1016/s0014-5793(04)00134-6 ↗
39. 10.1016/s0960-9822(02)00450-510.1016/s0960-9822(02)00450-5 ↗
40. 10.1039/c4gc01815j10.1039/c4gc01815j ↗
41. Boateng J. S. · Austin J. Anal. Pharm. Chem. · 2014 · 1 · 1
42. 10.1039/c6ra25264h10.1039/c6ra25264h ↗
43. 10.1016/j.micromeso.2008.12.01910.1016/j.micromeso.2008.12.019 ↗
44. 10.2174/138920303348721610.2174/1389203033487216 ↗